Aetna (Commercial) · spinal cord stimulation
✓ conditional · commercial
Criteria checklist
0 of 8 ticked- enumerated: yes
- covered:
- name: Failed back surgery syndrome (FBSS)
- requires:
- low back pain
- significant radicular pain
- name: CRPS I/II (RSD / causalgia)
- ref: Budapest Criteria
- name: Inoperable chronic ischemic limb pain (peripheral vascular disease)
- name: Chronic neuropathic pain — specified origins (last resort)
- origins:
- lumbosacral arachnoiditis
- phantom limb/stump
- peripheral neuropathy (incl. diabetic peripheral neuropathy)
- post-herpetic neuralgia
- intercostal neuralgia
- cauda equina injury
- incomplete SCI
- plexopathy
- criteria:
- vas min: 5
- pain present months: 12
- framing: last resort
- name: Intractable angina (DCS as DME) — not a surgical candidate
- criteria:
- cad: angiographically documented significant CAD; not a candidate for CABG or PTCA
- pharmacotherapy: >=1 month optimal (max tolerated doses of >=2 of: long-acting nitrates, beta-blockers, calcium-channel antagonists)
- nyha class:
- III
- IV
- reversible ischemia: documented by symptom-limited treadmill exercise test
- trial: >=50% pain reduction with a 3-7 day percutaneous trial
- investigational:
- replacing a FUNCTIONING standard DCS with HF/burst/DTM (waveform upgrade of a working device); battery change for paresthesia on a working device
- repeat trial after a failed trial, absent extenuating circumstances (lead migration, infection, anatomic difficulty)
- cervical DCS (any non-CRPS indication)
- DCS + DRG combined
- concurrent two DCS
- intra-op MEP/SSEP monitoring
- chronic malignant pain; pelvic/visceral pain; coccydynia; gastroparesis; IBS
- required: yes
- min duration months: 6
- min classes: 3
- classes:
- NSAIDs
- TCAs
- SSRIs
- SNRIs
- muscle relaxants (tizanidine/cyclobenzaprine/baclofen)
- anticonvulsants
- also requires:
- formal IN-PERSON physical therapy with a licensed PT >=6 weeks within the past year (not virtual)
- psychological therapies
- required: yes
- min duration days:
- 3
- 7
- success criteria:
- pain reduction pct: 50
- functional improvement: implied
- threshold is binding: yes
- required: yes
- must clear: yes
- note posture: clearance obtained from a psychiatrist/psychologist/qualified MH professional (e.g., LCSW) pre-authorization
- substance use exclusion: no untreated substance use disorder (ASAM)
- applies: yes
- trial: <=16 contacts / 2 perc leads / 1 paddle
- implant: additional <=16 contacts / 2 perc leads / 1 paddle
- covered when: positive prior DCS response AND manufacturer interrogation documents IPG 'end of life' or unrepairable
- waveform upgrade of working device: not_covered
Aetna is not the dominant commercial book in IN/KY (Anthem/Elevance is), but this cell is now fully source-verified against the LIVE current CPB 0194 (Last Review 2026-05-21), pulled via the in-session browser 2026-07-24 (the Incapsula bot-gate passed). The 2026 version is materially stricter than the 2019 cache the cell was seeded from: a completed multidisciplinary work-up is required — >=6 months of failed conservative care (>=3 medication classes AND in-person PT >=6 weeks in the past year AND psychological therapies), psychological CLEARANCE pre-auth, no untreated substance use disorder (ASAM), an ODI functional score >=21%, advanced thoracic CT/MRI showing no lead-placement contraindication, all other pain sources ruled out (FBSS additionally requires imaging proof of the prior surgery), and a successful 3-7 day, >=50% trial. Covered indications: FBSS, CRPS I/II (Budapest), inoperable chronic ischemic limb pain, last-resort neuropathic pain of specified origins (VAS>=5, present >=12 months), and intractable angina (DCS as DME). HF (Senza), burst (BurstDR), and DTM (Medtronic) are equal to standard DCS; upgrading a WORKING device is not covered.
Ticks are a documentation aid — nothing is stored; they reset on reload.
Dot phrase
Lean narrative A&P attestation. `***` = fill-in. Every clinical assertion maps to an Aetna CPB 0194 condition (current 2026-05-21 review).
.SCSTRIALAETNA Assessment: *** — covered indication (select one): FBSS with low back pain AND significant radicular pain | CRPS I/II (Budapest criteria) | inoperable chronic ischemic limb pain from peripheral vascular disease | chronic neuropathic pain of specified origin (lumbosacral arachnoiditis / phantom limb-stump / peripheral neuropathy incl. diabetic / post-herpetic neuralgia / intercostal neuralgia / cauda equina injury / incomplete SCI / plexopathy), which for this class alone additionally requires VAS ***/10 (>=5), pain present >=12 months, and SCS pursued as a last resort | intractable angina (separate angina criteria set). Medical necessity per Aetna CPB 0194 (Spinal Cord Stimulation): conservative care has been tried and has failed over >=6 months — *** — comprising at least three medication classes (NSAIDs / TCAs / SSRIs / SNRIs / muscle relaxants / anticonvulsants), formal in-person physical therapy with a licensed PT for >=6 weeks within the past year, and psychological therapies. Pre-procedure psychological clearance was obtained from *** (psychiatrist / psychologist / LCSW) before authorization, and there is no untreated substance use disorder by ASAM criteria. Functional disability is documented at an Oswestry Disability Index of ***% (>=21%). Thoracic CT/MRI *** shows no anatomic contraindication to lead placement and all other reasonable sources of pain have been ruled out; where the indication is FBSS, the imaging demonstrates the prior surgery. Any prior spinal surgery is >=6 months out. Plan: Percutaneous SCS trial of 3-7 days, with trial hardware within the covered cap (<=16 contacts / 2 percutaneous leads / 1 paddle). Permanent implantation requires >=50% reduction in target pain during the trial, documented by the trial placement and lead-pull notes. Risks, benefits, and alternatives discussed; consent obtained.
Where this payor diverges from the Medicare baseline
Cautions
Prior-auth pathway
- required: yes
Provenance
- authority:
- type: commercial_policy
- id: Aetna CPB 0194
- title: Spinal Cord Stimulation
- supplements: NCD 160.7 / applicable LCDs (does not supersede)
- source: https://www.aetna.com/cpb/medical/data/100_199/0194.html
- effective: 1997-12-17 · payor last reviewed: 2026-05-21 · we verified: 2026-07-24 · v2
Change history
- 2026-07-24aetna/scs v2: CPB 0194 read LIVE via browser (Incapsula gate passed) at current 2026-05-21 review; the 2019-cache cell was materially out of date - corrected conservative floor 12mo->6mo + expanded med classes + in-person PT + psych therapies; ADDED ODI>=21%, thoracic CT/MRI + rule-out gates, FBSS prior-surgery imaging, intractable-angina indication, DTM waveform; needs_reverification cleared; dot phrase regenerated
9a1ed998bd - 2026-06-27Seed: locked schema + SCS templated for Medicare (NCD 160.7) and Aetna (CPB 0194)
89cec9dbfe